Targeted Medical Pharma, Inc. (TRGM)

Market Cap	29.00
Revenue (ttm)	5.26M
Net Income (ttm)	-3.04M
Shares Out	29.47M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	2,117
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-0.15
RSI	n/a
Earnings Date	n/a

About Targeted Medical Pharma

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyal...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 30
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRGM

Financial Performance

In 2015, Targeted Medical Pharma's revenue was $5.26 million, a decrease of -26.03% compared to the previous year's $7.11 million. Losses were -$3.04 million, -21.85% less than in 2014.